The National Pancreatic Cyst Registry | Welcome
799
page-template-default,page,page-id-799,ajax_leftright,page_not_loaded,boxed,no_delay

Welcome

 

The National Pancreatic Cyst Registry is a prospective study of integrated molecular pathology’s (PathFinderTG®, RedPath Integrated Pathology, Inc.) ability to predict the malignant potential of pancreatic cysts. Leading academic medical centers and community-based practices participated. RedPath provided sponsorship in part.

The goals of the study were to evaluate the performance characteristics and clinical utility of integrated molecular pathology and determine the predictive value of both traditional first-line tests and integrated molecular pathology.

Logistics »